EPISODE · Jul 7, 2025 · 12 MIN
ASCO 2025 Plenary - MATTERHORN
from Two Onc Docs
This week’s episode will be focusing on one of the GI plenary session abstracts presented at the ASCO Annual Meeting 2025, the MATTERHORN trial: phase 3 durvalumab + FLOT which is 5FU leucovorin, oxaliplatin and docetaxel in resectable gastric or GE junction CA.
NOW PLAYING
ASCO 2025 Plenary - MATTERHORN
No transcript for this episode yet
Similar Episodes
Feb 4, 2026 ·72m
Oct 22, 2025 ·38m
Oct 15, 2025 ·30m